| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EOG | Common Stock | Options Exercise | $380,200 | +4,000 | +11% | $95.05 | 41,611 | 01 Sep 2023 | Direct | |
| transaction | EOG | Common Stock | Disposed to Issuer | $380,246 | -2,916 | -7% | $130.40 | 38,695 | 01 Sep 2023 | Direct | |
| transaction | EOG | Common Stock | Tax liability | $34,426 | -264 | -0.68% | $130.40 | 38,431 | 01 Sep 2023 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EOG | Stock Appreciation Rights | Options Exercise | $0 | -4,000 | -100% | $0.000000* | 0 | 01 Sep 2023 | Common Stock | 4,000 | $95.05 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The SARs granted, which were scheduled to expire on September 29, 2023, became exercisable in 25 percent increments beginning one year from the September 29, 2016 date of grant and on each of the next three grant date anniversaries. The SARs granted became fully exercisable on September 29, 2020. This exercise did not involve any open-market sale of the Issuer's Common Stock. |